KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $1.1 billion.

  • Charles River Laboratories International's Total Current Liabilities rose 10.83% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 10.83%. This contributed to the annual value of $994.1 million for FY2024, which is 5.78% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Total Current Liabilities stood at $1.1 billion, which was up 3.84% from $1.1 billion recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Total Current Liabilities high stood at $1.1 billion for Q3 2025, and its period low was $803.4 million during Q1 2021.
  • In the last 3 years, Charles River Laboratories International's Total Current Liabilities had a median value of $1.0 billion in 2023 and averaged $1.0 billion.
  • Per our database at Business Quant, Charles River Laboratories International's Total Current Liabilities rose by 27.70% in 2021 and then dropped by 5.96% in 2024.
  • Charles River Laboratories International's Total Current Liabilities (Quarterly) stood at $1.0 billion in 2021, then increased by 5.65% to $1.1 billion in 2022, then dropped by 3.34% to $1.1 billion in 2023, then dropped by 5.78% to $994.1 million in 2024, then rose by 10.83% to $1.1 billion in 2025.
  • Its Total Current Liabilities stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.1 billion for Q1 2025.